The following publication shows the development of the first urology tissue engineering product starting from preclinic to market approval in Germany:
Abstract MP9-04: Preclinical and clinical examination of tissue-engineered graft for urethral reconstruction (MukoCell®) with regard to its safety
The quality and pre-clinical data of our lead product MukoCell have been certified by the European Medicines Agency (EMA).
MukoCell GmbH is particapting at the 29. Annual EAU Congress from April 11th – 15th 2014
MukoCell GmbH has received authorisation to distribute its product MukoCell® pursuant to Section 4b of the Medicinal Products Act (AMG) – „Special provisions governing advanced therapy medicinal products“.
In the article „Business creation in Germany / A slow climb – A vigorous start-up scene has yet to produce its first big breakthrough“ published in The Economist from 5th October 2013, the MukoCell GmbH gets mentioned as one of Germanys promising Start-up companies in the field of Bioengineering.
Tissue-engineering can help to overcome problems, associated with tissue limitations for urological reconstruction.
A live surgery about urethral reconstruction with MukoCell will be performed by Dr. Dahlem, UKE Hamburg between 1 p.m. and 3 p.m. on the 10th of October 2013
The MukoCell GmbH is particapting at the BioCapital Europe 2013, 17April 2013, in Amsterdam, Netherlands .